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Stem cells (SC) exhibit a unique capacity for
self-renewal in an undifferentiated state. It is un-
clear whether the self-renewal of pluripotent
embryonic SC (ESC) and of tissue-specific adult
SC such as hematopoietic SC (HSC) is con-
trolled by common mechanisms. The deletion
of transcription factor Zfx impaired the self-
renewal but not the differentiation capacity of
murine ESC; conversely, Zfx overexpression
facilitated ESC self-renewal by opposing differ-
entiation. Furthermore, Zfx deletion abolished
the maintenance of adult HSC but did not affect
erythromyeloid progenitors or fetal HSC. Zfx-
deficient ESC and HSC showed increased apo-
ptosis and SC-specific upregulation of stress-
inducible genes. Zfx directly activated common
target genes in ESC and HSC, as well as ESC-
specific target genes including ESC self-
renewal regulators Tbx3 and Tcl1. These stud-
ies identify Zfx as a shared transcriptional
regulator of ESC and HSC, suggesting a com-
mon genetic basis of self-renewal in embryonic
and adult SC.
INTRODUCTION
The development and function of multicellular organisms
are based on the activity of stem cells (SC). During early
embryonic development, pluripotent stem cells give rise
to all cell types in the body, including the germline (Boiani
and Scholer, 2005). In the adult, tissue homeostasis is
maintained by multipotent adult stem cells, which contin-
uously generate cell lineages comprising a given tissue. In
adult mammals, SC have been identified in many tissues
and organs, including the hematopoietic system, brain,skin, and intestine (Weissman et al., 2001). Whereas the
precise differentiation potential varies between different
SC types, all SC share the fundamental property of self-
renewal, i.e., the maintenance of their number and identity
in an undifferentiated state.
Embryonic stem cells (ESC) can be derived from plurip-
otent cells of the blastocyst inner cell mass and propa-
gated in vitro as continuous clonal lines (Chambers and
Smith, 2004). These ESC lines are capable of unlimited
growth in culture while retaining their undifferentiated
state and full developmental potential. Murine ESC are
typically cultured on fibroblast feeder cells with serum
and leukemia inhibitory factor (LIF), a cytokine that acti-
vates the essential gp130/Stat3 signaling pathway. Com-
bined with LIF, bone morphogenetic proteins (BMP) sup-
port unlimited ESC self-renewal in the absence of serum
or feeders (Ying et al., 2003). The pluripotency of ESC is
regulated by a unique network of ESC-specific transcrip-
tion factors including Oct4, Nanog, Sox2, and their bind-
ing partners (Boyer et al., 2005; Chambers and Smith,
2004; Wang et al., 2006). Indeed, a defined combination
of Oct4, Sox2, and other transcription factors is sufficient
to derive ESC-like pluripotent cells frommouse fibroblasts
(Takahashi and Yamanaka, 2006). In addition, a distinct
genetic pathway regulating ESC self-renewal involves
transcription factors Tbx3 and Esrrb and a signaling co-
factor Tcl1 (Ivanova et al., 2006).
Among adult SC types, one of the best characterized is
the blood-producing hematopoietic SC (HSC) of the adult
bone marrow (BM) (Kondo et al., 2003). These cells sus-
tain hematopoiesis throughout adult life and are capable
of clonal, long-term hematopoietic reconstitution of irradi-
ated recipients after serial transplantation. HSC are local-
ized in a distinct structural and functional compartment in
the BM, the HSC niche, which provides critical signals
supporting HSC self-renewal (Calvi et al., 2003; Zhang
et al., 2003). Upon differentiation, the bona fide long-
term repopulating HSC rapidly lose their self-renewal
potential, producing a hierarchy of multipotent short-
term HSC and/or multilineage progenitors, commonCell 129, 345–357, April 20, 2007 ª2007 Elsevier Inc. 345
lymphoid and myeloid progenitors, and lineage-commit-
ted precursors. In the adult mouse BM, all HSC activity
is contained in the rare (<0.1%) lineage marker (Lin)
Sca-1+ c-Kit+ (LSK) cell subset, which can be further sub-
divided to define the homogeneous long-term HSC popu-
lation. The self-renewal of adult HSC is regulated by
several broadly expressed transcription factors including
Bmi-1 (Lessard and Sauvageau, 2003; Park et al., 2003),
Tel/Etv6 (Hock et al., 2004) and FoxO (Tothova et al.,
2007).
Although both ESC and adult SC are capable of unlim-
ited self-renewal, their cellular and molecular features are
strikingly different. First, ESC can self-renew in defined
culture conditions in vitro, whereas the self-renewal of
adult SC typically depends on their in vivo niche (Li and
Xie, 2005). Furthermore, ESC are highly proliferative and
exhibit unusual features of cell-cycle control, such as the
lack of a G1 checkpoint (Burdon et al., 2002). In contrast,
a cardinal feature of adult SC is their low proliferation rate
(Li and Xie, 2005). Indeed, genetic manipulations that in-
crease HSC proliferation lead to HSC exhaustion and
eventual failure (Cheng et al., 2000; Yilmaz et al., 2006;
Zhang et al., 2006). In view of these fundamental differ-
ences between ESC and various adult SC, a major unre-
solved question is whether their self-renewal is regulated
by common genes and/or pathways (Eckfeldt et al.,
2005; Mikkers and Frisen, 2005). Such ‘‘stemness’’ genes
have been postulated on the basis of global expression
analysis of different SC populations (Ivanova et al., 2002;
Ramalho-Santos et al., 2002); however, they remain to
be reconciled between different studies and verified in
functional assays (Sakaguchi et al., 2006). Furthermore,
other studies emphasized the lack of a common gene ex-
pression program in ESC and adult SC (D’Amour and
Gage, 2003; Fortunel et al., 2003).
Zfx is a zinc finger protein of the Zfy family, whosemem-
bers are highly conserved in vertebrates. Mammalian Zfx
is encoded on the X chromosome and contains an acidic
transcriptional activation domain (AD), a nuclear localiza-
tion sequence (NLS), and a DNA binding domain (DBD)
consisting of 13 C2H2-type zinc fingers (Schneider-
Gadicke et al., 1989). A targeted mutation of murine Zfx
resulted in partially penetrant neonatal lethality and hypo-
fertility in surviving females (Luoh et al., 1997). However,
the possibility that the targeting created a hypomorphic
Zfx allele could not be ruled out. Recently, two microar-
ray-based expression studies suggested that Zfx might
be expressed at elevated levels in several SC types (For-
tunel et al., 2003; Ramalho-Santos et al., 2002), prompting
us to investigate the role of Zfx in SC function.
Here, we use conditional gene targeting to examine the
role of murine Zfx in two prototypical SC types, ESC and
adult HSC. We report that Zfx is required for the self-
renewal of both SC types, whereas it is dispensable for
the growth and differentiation of their progeny. These re-
sults establish Zfx as a shared transcriptional regulator
of embryonic and adult SC, suggesting a common molec-
ular basis of SC self-renewal.346 Cell 129, 345–357, April 20, 2007 ª2007 Elsevier Inc.RESULTS
Conditional Targeting of Murine Zfx
To confirm the elevated expression of Zfx in SC, we mea-
sured Zfx levels in SC by quantitative PCR (qPCR). As
shown in Figure 1A, the expression of Zfx was twice as
high in HSC and in undifferentiated ESC compared to their
respective differentiated progeny. To test the function of
Zfx in SC, we generated a conditional LoxP-flanked
(‘‘floxed’’) allele of murine Zfx by homologous recombina-
tion in ESC (Figure 1B and Figure S1 in the Supplemental
Data available with this article online). Cre-mediated re-
combination of the only Zfxflox allele in male Zfxflox/y cells
produced Zfxnull allele, which did not encode a detectable
protein product (Figure 1C). Embryos with germline Zfx
deletion developed normally until 9.5 d.p.c. and subse-
quently died due to extraembryonic tissue abnormalities
(data not shown). The embryoswith Zfx deletion in the em-
bryo proper died neonatally but were grossly normal at
18.5 d.p.c., with Zfxnull cells contributing extensively to
all tissues (Figure S2). Similarly, a nearly complete deletion
of Zfx in the absence of obvious abnormalities was ob-
served in embryos and newborns with early brain- or he-
matopoietic-specific Zfx deletion (Figure S2). These data
suggest that Zfx is dispensable for cell growth and differ-
entiation of most tissues in vivo.
Zfx Is Required for ESC Self-Renewal
To analyze the growth of Zfx-deficient ESC, we transiently
induced Cre recombination in Zfxflox ESC and cultured the
resulting mixture of recombined (Zfxnull) and unrecom-
bined ESC in the conditions favoring self-renewal (se-
rum/LIF/feeders). As shown in Figure 2A, Zfxnull ESC
were rapidly out-competed by Zfxflox cells and disap-
peared after two passages. In contrast, Zfxnull cells per-
sisted when ESC were allowed to differentiate in the ab-
sence of LIF/feeders. Moreover, a similar competition
assay revealed normal growth of Zfx-deficient primary
mouse embryonic fibroblasts (MEF), confirming a specific
role of Zfx in undifferentiated ESC.
To further characterize the phenotype of Zfx-deficient
ESC, we derived clonal Zfxnull ESC lines and then stably
re-expressed Zfx in these cells (Figure 2B). The resulting
Zfxnull ESC remained undifferentiated, as judged by the
expression of ESC marker alkaline phosphatase (Fig-
ure 2C) and key ESC regulators Nanog and Oct4 (Suppl.
Figure S3). Nevertheless, all Zfxnull clones (n = 10) ex-
hibited abnormal colony morphology, reduced clonogenic
capacity, slower growth and spontaneous apoptosis in
serum/LIF (Figures 2C–2E). The impaired self-renewal of
Zfxnull ESC was particularly evident in serum-free culture
with LIF and BMP4, in which Zfxnull clones failed to expand
and collapsed after two to three passages (Figure 2F).
During the initial growth in serum-free culture, Zfxnull cells
underwent massive apoptosis as revealed by increased
proportion of Annexin V-positive and hypodiploid cells
(Figures 2G and S3). Notably, nearly all (9/10) Zfxnull ESC
clones reconstituted with Zfx (Zfxnull + Zfx) regained
normal morphology and vigorous growth (Figures 2C, 2D,
2F, and 2G). These data demonstrate a specific and re-
versible defect in the growth and survival of undifferenti-
ated Zfx-deficient ESC.
Figure 1. The Expression Analysis and Conditional Targeting
of Zfx
(A) The expression of Zfx is elevated in undifferentialed murine ESC
and HSC. The ESC were grown in serum-free culture with LIF +
BMP4 (undifferentiated), BMP4 or medium alone (differentiated).
Wild-type BM was sorted into lineage-positive (Lin+) differentiated
cells and Lin populations including HSC (Sca-1+ c-Kit+), myeloid pro-
genitors (MP, Sca-1 c-Kit+) and lymphoid progenitors (LP, Sca-1low c-
Kitlow). Shown is normalized Zfx expression relative to the correspond-
ing SC sample as measured by qPCR.
(B) The strategy of Zfx gene targeting. Exons 10 and 11 encoding the
NLS and DBD of Zfx protein were flanked by LoxP sites (red triangles).
The neomycin resistance (neo) cassette flanked by FRT sites (blue tri-
angles) was excised from the targeted Zfxflox-neo allele by Flp-mediated
recombination. Cre-mediated recombination of either Zfxflox-neo or
Zfxflox allele produces the Zfxnull allele.
(C) The expression of Zfx protein in the wild-type (wt) or targeted ESC
clones, analyzed byWestern blottingwith antibodies against Zfx N-ter-
minal AD. The positions of full-length Zfx and of the predicted protein
encoded by the null allele (determined using the corresponding epi-
tope-tagged expression constructs) are indicated by filled and open
triangles, respectively.In contrast to their impaired self-renewal, the differenti-
ation capacity of Zfx-deficient ESC was intact. When in-
jected into mice, Zfxnull ESC efficiently produced tera-
tomas containing differentiated tissues from the three
germinal layers (Figure 3A). Despite the low efficiency of
chimera formation after blastocyst injection, Zfxnull ESC
contributed to the majority of adult tissues in chimeric
mice, including the germline (Figure 3B). The lack of con-
tribution to the thymus and BM is consistent with the es-
sential role of Zfx in adult hematopoiesis (see below). Fur-
thermore, Zfxnull ESC clones grew normally in short-term
differentiation cultures without LIF (Figures 3C and 3D)
and expressed appropriate differentiation markers
(Figure S3). Finally, Zfxnull ESC efficiently formed embryoid
bodies (EB) that expressed the expected markers of he-
matopoietic differentiation (Keller, 2005) such as b-globin
and Flk-1 (Figures 3D and 3E, and data not shown). These
results suggest that the loss of Zfx impairs the self-
renewal of undifferentiated ESC but does not affect their
developmental potential or the growth of their differenti-
ated progeny.
In the course of these experiments, we noticed that ESC
clones expressing higher levels of Zfx (Zfxnull + Zfx*,
Figure 2B) were less prone to differentiation. In short-
term differentiation culture without LIF, Zfx-overexpress-
ing ESC grew better than Zfxnull or Zfxflox ESC (Figure 3C)
and retained undifferentiated phenotype (Figure 3D), fol-
lowed by massive cell death after replating. Furthermore,
Zfxnull + Zfx* ESC generated small EB without cavities,
which lost the pluripotency marker Nanog but failed to ex-
press hematopoietic differentiation marker b-globin (Fig-
ures 3D and 3E). Finally, Zfx-overexpressing ESC failed
to efficiently generate teratomas or mouse chimeras
(data not shown). Thus, overexpression of Zfx appears to
facilitate ESC self-renewal in suboptimal conditions and
to opposeESCdifferentiation, the phenotype complemen-
tary to the loss of Zfx. Altogether, these data establish Zfx
as a critical and specific regulator of ESC self-renewal.
Zfx Is Required for the Self-Renewal of Adult HSC
To examine the role of Zfx in adult hematopoiesis, we gen-
erated Mx1-Cre+ Zfxflox/y conditional knockout (CKO)
mice, in which Cre-mediated Zfx deletion is induced by
interferonogen pI$C (Kuhn et al., 1995). Two weeks after
induction, total numbers of BM cells and of c-Kit+ Sca-1
myeloid progenitors were unaffected in CKO mice,
whereas the HSC-containing LSK population was signifi-
cantly (p < 0.0001) decreased (Figure 4A). Time course
analysis revealed a progressive loss of the HSC at 2–5
weeks after induction, resulting in the decreased ratio of
HSC to c-Kit+ Sca-1 myeloid progenitors (Figure 4B).
The fractions of erythroid and myeloid differentiated cells
were normal, while lymphocytes were initially depleted by
pI$C treatment and failed to regenerate in the CKO BM
(Figure S4). A similar loss of the LSK population was ob-
served after Zfx deletion induced by tamoxifen-activated
Cre construct (R26-CreER, Figure S5), ruling out potential
side effects of pI$C injection.Cell 129, 345–357, April 20, 2007 ª2007 Elsevier Inc. 347
Figure 2. Defective Self-Renewal of Zfx-Deficient ESC
(A) Impaired competitive growth of Zfx-deficient ESC but not of differentiated cells. Cre recombination was transiently induced in ESC or in primary
embryonic fibroblasts (MEF), and the presence of Zfxnull cells at subsequent passages (P) was monitored by genomic PCR. The ESC were grown in
serum/LIF/feeders (undiff.) or differentiated (diff.) into primitive embryoid bodies (EB) followed by adherent culture (A). Shown are the simultaneous
amplification of Zfxnull and Zfxflox alleles and the ratios of separately amplified alleles determined by qPCR.
(B) Re-expression of Zfx in Zfx-deficient ESC. Zfxnull ESC stably transfected with Zfx or control constructs (ctrl) were analyzed byWestern blotting with
anti-Zfx Ab. The clones overexpressing Zfx are indicated with an asterisk.
(C) Defective colony morphology of Zfx-deficient ESC. Shown are live cultures (magnification 100x) and fixed cells stained for alkaline phosphatase
(purple, magnification 2003) of ESC grown with serum/LIF/feeders.
(D) Defective growth and colony forming capacity of Zfx-deficient ESC clones in serum/LIF/feeders. Shown are numbers of colonies and total cell
yields of ESC (average ± SD of triplicate cultures) after one passage at single-cell (102/well) or regular (104/well) densities, respectively.
(E) Increased apoptosis of Zfx-deficient ESC clones grown in serum/LIF, as measured by DNA laddering assay (two clones per genotype).
(F) Defective growth of Zfx-deficient ESC clones in serum-free culture with LIF + BMP4. The data represent average cell yields of parallel triplicate
cultures for each clone.
(G) Increased apoptosis of Zfx-deficient ESC in serum-free culture. After one passage in LIF + BMP4, cells were stained for Annexin V and DNA con-
tent (7-AAD); the fraction of Annexin+ 7-AAD apoptotic cells is indicated.The consequences of constitutive Zfx deletion in hema-
topoietic cells were analyzed using the Tie2-Cre strain, in
which pan-hematopoietic Cre recombination is initiated in
the early embryo (Koni et al., 2001). Zfx deletion was inef-
ficient in most adult CKOmice, suggesting a strong selec-
tion against Zfxnull cells in adult hematopoiesis. Indeed,
the rare adult CKO mice with a complete Zfx deletion
(n = 5) showed the same specific loss of the HSC popula-348 Cell 129, 345–357, April 20, 2007 ª2007 Elsevier Inc.tion (Figure 4C). In contrast, the CKO fetal livers were uni-
formly Zfxnull (Figure S2), exhibited normal cellularity and
contained only a slightly reduced fraction of HSC (Fig-
ure 4C). Furthermore, primitive hematopoiesis in the yolk
sac of Zfxnull embryos was normal (Figure S6). Thus, the
absence of Zfx abolishes the maintenance of adult BM
HSC under steady-state conditions but largely spares
embryonic hematopoiesis.
Figure 3. Normal Differentiation Capac-
ity of Zfx-Deficient ESC
(A) Normal teratoma formation by control
(Zfxflox) and Zfxnull ESC clones (representative
of two clones per genotype). Differentiated tis-
sues in hematoxylin/eosin-stained sections of
teratomas are shown (magnification 200x).
(B) The contribution of Zfxnull ESC to tissues of
chimeric mice. Left panel: null and wild-type
Zfx alleles were separately amplified from ge-
nomic DNA of chimeric mouse tissues (repre-
sentative of three chimeras). Right panel: fe-
male progeny of a chimeric mouse were
genotyped, confirming germline transmission
of Zfxnull allele.
(C) The growth in differentiating conditions of
ESC clones lacking (Zfxnull) or overexpressing
(Zfxnull + Zfx*) Zfx. Shown are average cell
yields of triplicate cultures plated at 2 3 104/
well and grown for one passage without LIF
or feeders.
(D) The same ESC clones were grown without
LIF and stained for alkaline phosphatase (pur-
ple, upper panel) or induced to form mature
EB (lower panel). Magnification, 1003.
(E) The expression of pluripotency (Nanog) and
differentiation (b-globin) markers in undifferen-
tiated ESC or in EBmeasured by qPCR relative
to the expression in Zfxnull + Zfx ESC.Further analysis of the HSC/progenitor compartment in
induced Mx1-Cre CKO mice (Figure 4D) and in Tie2-Cre
CKOmice (Figure S7) confirmed the loss of Flt3 LSK sub-
set that contains the self-renewing long-term HSC. In ad-
dition, the Flt3+ LSK population containing short-term
HSC and c-Kitlow Flt3+ lymphoid progenitors including
IL-7Ra+ common lymphoid progenitors (CLP) were se-
verely reduced (Figures 4D, S4, S5, and S7). The HSC in
induced Mx1-Cre+ CKO mice proliferated normally, did
not show increased egress from the BM, and displayed
normal homing to and lodging in the BM after adoptive
transfer (Figure S8). On the other hand, Zfx-deficient
HSC showed a significant (p = 0.0002) increase in Annexin
V-positive apoptotic cells (Figure 4E). In contrast, the Lin
Sca-1 c-Kit+ erythromyeloid progenitors were presentin normal numbers, contained common and lineage-
restricted subsets (Figure 4D), did not show increased
apoptosis (Figure 4E), and maintained their characteristi-
cally high proliferation rate (Figure S8). Indeed, control
and CKO BM generated similar numbers of erythroid
andmyeloid colonies in short-term colony-forming assays
(Figure 4F). These observations suggest that Zfx is re-
quired for the long-term survival of HSC but is dispensable
in erythromyeloid progenitors.
Consistent with the defective maintenance of Zfx-defi-
cient HSC, the BM from inducedMx1-Cre CKOmice failed
to contribute to hematopoiesis in competitively reconsti-
tuted BM recipients (Figures 5A and 5B). To measure the
maintenance of HSC independent of their homing or en-
graftment, we induced the loss of Zfx in pre-establishedCell 129, 345–357, April 20, 2007 ª2007 Elsevier Inc. 349
Figure 4. The Loss of Adult HSC after Zfx Deletion in Hematopoietic Cells
(A) The decrease in HSC numbers after Zfx deletion from the BM. Shown are absolute numbers of total BM cells, myeloid progenitors and the HSC-
containing LSK population in control and Mx1-Cre+ Zfxflox/y CKO mice two weeks after pI$C injection. Each symbol represents an individual mouse.
(B) The loss of HSC from the stem/progenitor compartment of Mx1-Cre+ CKO BM at the indicated times after pI$C injection. Shown are the staining
profiles of Lin cells, with the LSK population (red) and erythromyeloid progenitors (blue) and their percentages indicated (average ± SD of 3–12
animals). The graph shows average ratios of the LSK to myeloid progenitor fractions.
(C) The loss of adult HSC after constitutive Zfx deletion in the hematopoietic system. The HSC and myeloid progenitor populations in the fetal liver
(n = 6–9) or in adult BM (n = 4–5) of Tie2-Cre+ CKO and control mice are shown as in panel (B).
(D) Decreased HSC and lymphoid progenitors but normal myeloid progenitors inMx1-Cre+ CKOmice two weeks after pI$C injection. Shown are Flt3
and Flt3+ LSK populations containing long-term and short-termHSC, respectively; Flt3+ Lin c-Kitlow lymphoid progenitors including the IL-7Ra+ CLP
subset (red); and Lin Sca-1 c-Kit+ erythromyeloid progenitors divided into common myeloid progenitor (red), erythrocyte/megakaryocyte progen-
itor (blue), and granulocyte/monocyte progenitor (green). The fraction of each subset in the Lin population is indicated (average ± SD of 5 animals).
(E) Increased HSC apoptosis in Mx1-Cre+ CKOmice two weeks after pI$C injection. Shown are gated HSC (the LSK subset) and erythromyeloid pro-
genitors (Lin Sca-1 c-Kit+) stained for Annexin V and DNA content (7-AAD). The fractions of Annexin+ 7-AAD apoptotic cells (highlighted) are
indicated (average ± SD of 3 animals).350 Cell 129, 345–357, April 20, 2007 ª2007 Elsevier Inc.
BM chimeric mice (Mikkola et al., 2003). Irradiated recipi-
ent mice (CD45.1+ CD45.2+) were transplanted with amix-
ture of donor BM from uninduced Mx1-Cre+ CKO or
control mice (CD45.2+) and competitor wild-type BM
(CD45.1+). Four weeks later, chimeric mice were injected
with pI$C to induce Zfx loss in the engrafted CKO BM,
and the fraction of donor-derived peripheral blood leuko-
cytes (PBL) was subsequently monitored (Figure 5C). In
contrast to all control recipient groups, the pI$C-injected
recipients of CKO BM manifested a sharp decline of do-
nor-derived PBL (Figures 5D and 5E). The endpoint analy-
sis 6 months after induction confirmed the virtual absence
of Zfx-deficient donor cells in all hematopoietic cell types,
including the HSC-containing LSK subset (Figure 5F).
These results demonstrate at the functional level that Zfx
is absolutely required for the long-termHSCmaintenance.
A Common Gene Expression Signature
of Zfx-Deficient SC
To identify Zfx target genes in SC, we compared global ex-
pression profiles of control and Zfx-deficient ESC and
HSC. Several genes that were affected by Zfx loss in
both ESC and HSC were identified, including 5 down-
regulated genes (6 probes, p = 0.0075) and 20 upregu-
lated genes (22 probes, p = 7 3 108) (Figure 6A and
Table S1). In the latter group, a more permissive analysis
suggested several additional candidates. By qPCR
(Figure 6B and Table S2), four downregulated genes
(6720467C03Rik, AV340375, Phca, and Retsat) and six
upregulated genes (Procr, Pkia, Ier3, Cryab, Gem, and
Ptgs2) were validated as differentially expressed, reveal-
ing a common expression signature of Zfx-deficient ESC
and HSC.
The predicted regulatory regions of commonly downre-
gulated genes contain multiple potential binding sites for
Zfx (Figure S9). To analyze the binding of Zfx to these ge-
nomic regions in live SC, we performed chromatin immu-
noprecipitation (ChIP) of epitope-tagged Zfx expressed in
Zfxnull ESC (Zfxnull + ZfxTAG, Figure S10). We found that
promoter regions of 6720467C03Rik, AV340375 and Re-
tsat were significantly enriched in ChIP with anti-tag anti-
bodies; in contrast, no enrichment was seen in parental
Zfxnull ESC that do not express tagged Zfx (Figure 6C). Fi-
nally, the expression of all three genes was increased in
Zfx-overexpressing ESC clones (Table S2). These results
suggest that genes commonly downregulated in Zfxnull
ESC and HSC are direct targets of Zfx.
Among the six genes coordinately upregulated in Zfx-
deficient ESC and HSC, four (Cryab, Ier3, Gem, and
Ptgs2) are known to be induced by stress, inflammatory
stimuli and/or growth factors, with the latter three repre-
senting immediate-early genes. Therefore, their induction
could be indirect and reflect the impaired function of Zfx-
deficient SC. Indeed, four genes (Pkia, Cryab, Ier3, andPtgs2) were upregulated in Zfxnull ESC and HSC, but not
in their respective differentiated progeny (Figure 6D). No-
tably, three genes (Gem, Procr, and Pkia) display highly
HSC-specific expression pattern (Ivanova et al., 2002;
and this study). The specific upregulation of Procr in Zfx-
deficient HSC was confirmed by cell-surface staining for
its product CD201 (Figure S11). Thus, the impaired self-
renewal of Zfx-deficient ESC and HSC correlates with
SC-specific upregulation of stress-inducible and/or im-
mediate-early genes.
Zfx Controls ESC-Specific Regulators Tbx3 and Tcl1
To test whether Zfx controls genes and pathways specific
only for a particular SC type, we analyzed known ESC-
specific regulators of self-renewal. By protein staining
(Figure S3), microarray analysis (Table S3), and qPCR
(Figure 7A), the components of the Nanog/Oct4/Sox2
transcriptional network were only minimally affected in
Zfxnull ESC. On the other hand, we observed the downre-
gulation of several ESC-specific genes including Dub1/2,
Ceacam1, and particularly Tbx3, which encodes a tran-
scription factor required for ESC self-renewal (Ivanova
et al., 2006). Further qPCR analysis showed that another
ESC-specific regulator, Tcl1, was similarly reduced in
Zfxnull ESC. Short-term batch culture of ESC after Cre-me-
diated Zfx deletion showed a prominent reduction of Tbx3
and a slight decrease of Tcl1, but not ofNanog (Figure 7B).
Finally, Zfx-overexpressing ESC expressed higher levels
of Tbx3 and Tcl1, whereas Nanog and Oct4 were un-
changed (Figure 7C).
The predicted promoter regions of Tbx3 and Tcl1 con-
tain multiple consensus binding sites for Zfx (Figure S12).
In the case of Tbx3, ChIP analysis localized the region of
prominent Zfx binding to 0.5 Kb upstream of the tran-
scription start site (Figure 7D). Indeed, the binding of Zfx
to Tbx3 and Tcl1 promoters was detected only in Zfx-
expressing Zfxnull + ZfxTAG ESC, but not in the parental
Zfxnull ESC (Figure 7E). Finally, Zfx binding to Tbx3 pro-
moter was observed in undifferentiated ESC but not in
ESC differentiated without LIF, consistent with the rapid
loss of Tbx3 expression upon differentiation (Figure 7F).
These data suggest that Zfx directly controls the expres-
sion of self-renewal regulators Tbx3 and Tcl1 in undiffer-
entiated ESC.
DISCUSSION
In this paper, we examined the biological role of Zfx, one of
the first identified zinc finger-encoding genes (Schneider-
Gadicke et al., 1989) whose properties and function re-
mained unclear. We found that Zfx deletion impaired the
growth of ESC in vitro and increased their apoptosis
rate, particularly in defined serum-free conditions. Despite
the growth and survival defect, Zfx-deficient ESC(F) Normal erythromyeloid progenitor function in Zfx-deficient BM. Shown is in vitro colony formation by BM cells fromMx1-Cre+ CKO or control mice
two weeks after pI$C injection (average ± SD of 4 animals).Cell 129, 345–357, April 20, 2007 ª2007 Elsevier Inc. 351
Figure. 5. The Loss of Zfx Abolishes HSC Function
(A and B) Defective hematopoietic reconstitution by Zfx-deficient BM. Control or Mx1-Cre+ CKOmice (CD45.2+) were injected with pI$C to induce Zfx
deletion, and their BM was mixed with wild-type competitor BM (CD45.1+) and transferred into irradiated CD45.1+ recipients. Shown are represen-
tative staining profiles of PBL (A) and the fractions of donor-derivedCD45.2+ cells in the indicated lineages (B) twomonths after BM transfer (average ±
SD of 3 recipients).
(C–F) The loss of HSC maintenance after Zfx deletion in pre-established BM chimeras. (C) Experimental strategy. (D) Representative staining profiles
of total PBL in the recipient mice before or 6 months after pI$C injection, showing donor (CD45.2+CD45.1, highlighted), competitor
(CD45.2CD45.1+) and residual host (CD45.2+CD45.1+) cells. (E) Relative contribution of donor-derived cells to major PBL lineages over time. The
donor-derived fraction before pI$C injection (>50% in all mice) was taken as one for each recipient; the data represent average ± SD of 4 recipients
per group. A representative of 3 independent reconstitution experiments is shown. (F) The percentage of donor-derived cells in the indicated cell sub-
sets in the thymus and BM 6 months after pI$C injection.remained undifferentiated and gave rise to all lineages,
including the germline. Conversely, stable Zfx overexpres-
sion favored ESC self-renewal at the expense of differen-
tiation. The requirement for Zfx in ESC self-renewal in vitro352 Cell 129, 345–357, April 20, 2007 ª2007 Elsevier Inc.is not contradicted by the relatively normal early develop-
ment of Zfxnull embryos, which survive until midgestation.
Indeed, early embryonic development is not affected by
the loss of several ESC self-renewal regulators such as
Figure 6. A Common Gene Expression Signature of Zfx-Deficient ESC and HSC
(A) Genome-wide expression analysis of Zfx-deficient ESC and HSC using microarrays. Data points represent normalized increase (>0) or decrease
(<0) in individual probe levels in Zfxnull ESC and HSC relative to the respective controls. Probes showing coordinated decrease or increase in Zfxnull
ESC and HSC are indicated as large blue and red dots, respectively; small colored dots represent a more permissive analysis. The numbers of total
and coordinately changing probes are indicated.
(B) The downregulation of common target genes in HSC and ESC after Zfx deletion. HSCwere sorted from control andMx1-Cre+ CKOBM4days after
pI$C injection. Short-term batch cultures of Zfxnull ESC were generated by sorting Zfxflox-neo ESC transfected with Cre-GFP. The data represent fold
decrease of the indicated transcripts in Zfxnull over control SC as determined by qPCR.
(C) Binding of Zfx to its common target genes in ESC. ChIP using anti-epitope tag antibodies was performed on Zfxnull ESC reconstituted with tagged
Zfx (Zfx-TAG) or on control Zfxnull ESC (null). The enrichment of promoter (P) or intron (I) regions of the indicated target genes in anti-tag antibody ChIP
compared to control IgG ChIP was determined by qPCR. The promoter of b-actin was used as a negative control. The regulatory regions of Phca
could not be reliably amplified by qPCR.
(D) A common gene induction signature of Zfx-deficient ESC and HSC. The ESC include control (Zfxflox) and Zfxnull clones grown as undifferentiated
cells or differentiated for 1 or 2 passages without LIF (Diff. P1-P2). The HSC (LSK population), myeloid progenitors and Lin+ cells were sorted from
control and Mx1-Cre+ CKO mice 4 days after the last pI$C injection. Data represent expression levels determined by qPCR relative to the respective
control SC sample (assigned an arbitrary value of 100).Eras (Takahashi et al., 2003), Tcl1, Essrb, or Tbx3 (Ivanova
et al., 2006). Thus, our data suggest a critical role of Zfx in
promoting ESC self-renewal, while it appears dispensable
for ESC pluripotency.
In addition, we found that Zfx is not required for fetal he-
matopoiesis but essential in adult HSC, which failed to
maintain their numbers or contribute to hematopoiesis
after Zfx deletion. Zfx-deficient HSC interacted normallywith their BM niche but showed an increase in apoptosis,
suggesting a defect of long-term self-renewal due to im-
paired survival. In contrast, the survival and function of
erythromyeloid progenitors were not affected, at least in
the short term. Very similar phenotypes have been ob-
served after the inducible deletion of Tel/Etv6 (Hock
et al., 2004) or FoxO1/3/4 (Tothova et al., 2007), or after
germline deletion of Bmi-1 (Park et al., 2003) or IkarosCell 129, 345–357, April 20, 2007 ª2007 Elsevier Inc. 353
Figure 7. Zfx Controls Tbx3 and Tcl1 Expression in ESC
(A) The expression of ESC-specific genes in Zfx-deficient ESC. Control (Zfxflox) and Zfxnull ESC clones grown in LIF or differentiated for 1 or 2 passages
without LIF (P1-P2) were analyzed by qPCR. Data represent expression levels of the indicated genes relative to undifferentiated control ESC (assigned
an arbitrary value of 100).
(B) The expression of Tbx3 and Tcl1 in polyclonal ESC after Zfx deletion. The data represent fold decrease of the indicated genes in Zfxnull over control
ESC in short-term batch cultures as determined by qPCR.
(C) The expression of Tbx3 and Tcl1 in Zfx-overexpressing ESC as determined by qPCR. The data show fold increase of the indicated genes in Zfx-
overexpressing ESC (Zfxnull + Zfx*, Figure 2B) over control ESC (Zfxnull + Zfx).
(D) The region of Tbx3 promoter bound by Zfx in ESC. The Zfxnull ESC reconstituted with tagged Zfx (Zfx-TAG) or control Zfxnull ESCwere analyzed by
ChIP as in Figure 6C. Data represent the enrichment of different regions of Tbx3 upstream region, shown belowwith the 50 UTR (open box) and the first
coding exon (black box).
(E) The binding of Zfx to the promoter regions of Tbx3 and Tcl1 in Zfx-expressing (Zfx-TAG) and Zfx-deficient (null) ESC. Shown is fold enrichment of
the control target 6720467C03Rik, Tcl1 promoter, and Tbx3 promoter (P) or distal 50 region (50) indicated in panel (D).
(F) Increased binding of Zfx to Tbx3 promoter in undifferentiated versus differentiated ESC. Shown is fold enrichment of control target
6720467C03Rik, Tbx3 promoter (P) or distal 50 region (50) in Zfx-expressing ESC (Zfx-TAG) grown with LIF (undiff.) or differentiated for two passages
without LIF (diff.).(Nichogiannopoulou et al., 1999) transcription factors.
Similar to the latter three models, lymphopoiesis was se-
verely impaired after the loss of Zfx. Thus, Zfx and possibly354 Cell 129, 345–357, April 20, 2007 ª2007 Elsevier Inc.other HSC regulators appear to control both HSC self-
renewal and lymphoid differentiation, but not erythromyeloid
differentiation. Alternatively, the failure of lymphoid
development might be secondary to defective HSC func-
tion, while erythromyeloid progenitors might be less de-
pendent on HSC input (Nichogiannopoulou et al., 1999).
Although several transcriptional regulators were shown
to control multiple SC types, the common regulation of
ESC and adult SC has been difficult to demonstrate. For
instance, Polycomb group (PcG) protein Bmi-1 promotes
the self-renewal of HSC and of neural SC through the re-
pression of Cdkn2a products p16Ink4a and/or p19Arf (Les-
sard and Sauvageau, 2003; Molofsky et al., 2003; Park
et al., 2003). On the other hand, ESC are resistant to
p16Ink4a and to other cyclin inhibitors (Burdon et al.,
2002), and are not known to depend on Bmi-1. Con-
versely, PcG protein Eed contributes to the repression of
differentiation-associated genes in ESC (Azuara et al.,
2006; Boyer et al., 2006); however, Eed promotes prolifer-
ation and antagonizes Bmi-1 in hematopoietic cells (Les-
sard et al., 1999). In another case, transcription factor
Sox2 controls the pluripotency of ESC and of neural
stem/progenitor cells (Boyer et al., 2005; Graham et al.,
2003; Ivanova et al., 2006). However, Sox2 is not ex-
pressed in other adult SC types, including HSC, and its
specific role in adult neural SC remains to be established.
Thus, Zfx provides a rare example of a transcription factor
that is specifically required in ESC and in a canonical adult
SC population such as the HSC.
Because the common transcriptional regulation of ESC
and HSC has not been previously described, it is likely to
be based on equally novel molecular mechanisms. In-
deed, we have identified several direct target genes of
Zfx in ESC and HSC, all of which are either predicted or
poorly characterized. While the exact function of these di-
rect Zfx targets is currently unknown, their coordinate reg-
ulation in ESC and HSC supports the common role of Zfx
in these SC types. In addition, we identified several genes
upregulated in Zfx-deficient ESC and HSC, likely as an in-
direct consequence of Zfx loss. Most of the coordinately
induced genes are targets of stress, growth factor signal-
ling, and/or immediate-early response, suggesting that
Zfx-deficient SC undergo excessive stress. This is consis-
tent with increased apoptosis rate of Zfxnull ESC and HSC;
furthermore, both immediate-early gene induction and de-
creased survival occur in undifferentiated ESC and HSC,
but not in their differentiated progeny. Of note, HSC are
uniquely sensitive to certain forms of stress such as phys-
iological oxidative stress (Tothova et al., 2007). Altogether,
our data reveal the apoptosis and concomitant upregula-
tion of stress-inducible genes as common features of im-
paired self-renewal in ESC and HSC.
In addition to the common target genes, Zfx can directly
activate cell type-specific targets, such as Tbx3 and Tcl1
in ESC. Both genes are rapidly downregulated upon ESC
differentiation and facilitate ESC self-renewal through
a putative common pathway (Ivanova et al., 2006). Re-
cently, Tcl1 was shown to control ESC growth but not their
differentiation status (Matoba et al., 2006). Thus, Zfx may
promote ESC self-renewal at least in part through the di-
rect coordinate regulation of Tbx3 and Tcl1. Furthermore,the ESC-specific expression of Tbx3 and Tcl1 may par-
tially explain the requirement for Zfx in ESC but not in their
differentiated progeny. Although none of the known HSC
regulators were affected by the loss of Zfx (Table S3
and data not shown), Zfx may similarly regulate a yet un-
known HSC-specific self-renewal pathway. At present,
the ESC system provides a proof of principle that Zfx
can control self-renewal pathways specific for a particular
SC type.
In conclusion, our study has identified Zfx as a shared
transcriptional regulator of two prototypical yet highly dif-
ferent murine SC types, the embryonic and hematopoietic
SC. These results provide genetic evidence for a common
molecular basis of self-renewal in pluripotent embryonic
SC and adult tissue-specific SC. The identification of Zfx
should facilitate the molecular dissection of self-renewal
mechanisms in ESC, HSC, and possibly in other SC types,
including tumor-initiating cancer SC. Finally, the high evo-
lutionary conservation of Zfx raises the possibility that it
may regulate SC functions in other vertebrate species, in-
cluding humans.
EXPERIMENTAL PROCEDURES
Gene Targeting
Conditional targeting, deletion and re-expression of Zfx in ESC were
performed in male 129/SvEv ESC as described in Figure S1 and Sup-
plemental Experimental Procedures. The presence of Zfx protein was
analyzed with an affinity-purified polyclonal antibody against the N-
terminal domain. Zfxflox and Zfxnull ESC clones were injected into
C57BL/6 blastocysts, and the resulting chimeric males were crossed
to wild-type 129/SvEv and Black Swiss females, respectively.
To obtain CKO mice (Zfxflox/y, Cre+), Zfxflox/flox females (pure 129/
SvEv background) were crossed with males carrying Mx1-Cre (129/
SvEv) or Tie2-Cre (mixed 129/B6) transgenes. Control mice in both
strains included Cre+ wild-type and Cre Zfxflox/y animals, which
were indistinguishable by all assays. Mice carrying a tamoxifen-induc-
ible Cre recombinase inserted into Rosa26 locus (R26-CreER, C57BL/
6) were kindly provided by Dr. Thomas Ludwig, Columbia University.
The recombination in adult Mx1-Cre mice was induced with polyinosi-
nic:polycytidylic acid (pI$C, Amersham Biosciences) administered i.p.
three times (0.25 mg every third day). The deletion status of all ana-
lyzed CKO cells and tissues was monitored by genomic PCR. All ani-
mal studies were performed according to the investigator’s protocol
approved by the Institutional Animal Care and Use Committee.
Cell Culture and Analysis
Undifferentiated ESC were cultured in complete DMEM containing
15% FCS and recombinant LIF (Chemicon) on mitomycin-treated em-
bryonic fibroblast feeders. For gene expression studies and ChIP, ESC
were grown on gelatin-coated plates in 5%–15% Knockout SR serum
replacement (Invitrogen) and LIF. Serum- and feeder-free culture in the
presence of LIF and 10 ng/ml recombinant BMP4 (R&D Systems) was
performed as described (Ying et al., 2003). To measure cell growth or
colony formation, ESC were seeded into triplicate wells of 24-well
plates and cultured as indicated. Apoptosis of ESC was measured
by gel fractionation of low molecular weight DNA or by staining live
cells with Annexin V-FITC conjugate (BD Pharmingen) and 7-amino-
actinomycin D (7-AAD). For competitive growth assay, Zfxflox-neo
ESC were transiently transfected with Cre expression vector and
grown as indicated. For the batch culture of Zfxnull ESC shortly after
Zfx deletion, Zfxflox-neo ESC were transiently transfected with Cre-
GFP expression vector, and GFP+ cells were sorted 24 hr later andCell 129, 345–357, April 20, 2007 ª2007 Elsevier Inc. 355
cultured for 3 days with LIF on gelatin. Control ESC were generated in
parallel by transfection with an empty expression vector.
For differentiation, ESCwere grown in 15% FCSwithout LIF/feeders
on gelatin-coated plates. Where indicated, ESC were cultured in sus-
pension for 4 days to form primitive embryoid bodies (EB), and then re-
turned to adherent culture or allowed to form mature EB in suspension
for additional 4–9 days. For teratoma formation, undifferentiated ESC
grown on gelatin were injected s.c. into syngeneic 129/SvEv mice,
and teratomas were harvested 3 weeks later, sectioned, and stained
with hematoxylin-eosin.
Mouse embryonic fibroblasts (MEF) were derived from 14.5 d.p.c.
R26-CreER+, Zfxflox/y embryos. After the first passage, half of the cul-
ture was incubated with 4-hydroxytamoxifen to induce Zfx deletion,
and then equal numbers of treated and untreated cells were mixed
and propagated by the 3T3 protocol.
Hematopoietic Cell Analysis
Single-cell suspensions from hematopoietic organs were stained with
the indicated fluorochrome-conjugated antibodies (BD Pharmingen
and eBiosciences) for 4- or 5-color analysis. The lineage cocktail in-
cluded antibodies to CD11b, Gr-1, Ter119, B220, CD3, and DX5. For
apoptosis detection, enriched lineage-negative BM cells were stained
with antibody conjugates, Annexin V TACS reagent (Trevigen) and 7-
AAD. The samples were acquired using FACSCalibur or LSR II flow cy-
tometers or sorted on FACSAria flow sorter (BD Immunocytometry
Systems), and analyzed using FlowJo software (Treestar Inc.). Statis-
tical significance was estimated using unpaired, two-tailed Student’s
t test. For competitive reconstitution, BM cells from control (Mx1-
Cre+) or CKO (Zfxflox/y, Mx1-Cre+) mice 7 days after pI$C injection
was mixed 2:1 with the competitor BM cells from B6.SJL mice
(C57BL/6 congenic for CD45.1), and 2 3 106 total cells were injected
i.v. into lethally irradiated B6.SJL recipients. For Zfx deletion in pre-
established BM chimeras, BM cells from untreated Mx1-Cre+ control
or CKO mice were mixed 2:1 with competitor B6.SJL BM and injected
i.v. into lethally irradiated (129/SvEv 3 B6.SJL)F1 recipients. Four
weeks later, one half of each recipient group was treated with pI$C.
For progenitor assays, total BM was plated in triplicates (105 cells/35
mm dish) into cytokine-supplemented methylcellulose medium (Me-
thocult, Stem Cell Technologies), and the number and morphology
of colonies were scored 10 days later.
Global Gene Expression Analysis
For ESC, Zfxnull and control Zfxflox-neo clones were grown on gelatin in
medium with 15% Knockout SR and LIF. For HSC, BM cells were
pooled from 4–6 Mx1-Cre+ Zfxflox/y CKO and control Zfxflox/y Cre
littermates 4 days after the last pI$C injection, and Lin Sca-1+ c-Kit+
cells were flow-sorted. RNA was amplified, labeled and hybridized to
Mouse Genome 430 2.0 microarrays containing probes for 37,000
genes (Affymetrix). Details of the sample preparation and analysis
are described in Supplemental Experimental Procedures. Microarray
data have been deposited in the GEO database under accession num-
ber GSE7069.
Quantitative PCR
Total cell RNA was reverse-transcribed and assayed by quantitative
real-time PCR using SYBR Green incorporation. The expression of
all genes was normalized to that of b-actin and expressed relative to
the indicated reference sample (average ± SD of triplicate reactions).
For competition experiments (Figure 2A), Zfxflox and Zfxnull alleles
were amplified separately and normalized using qPCR reaction that
detects all targeted Zfx alleles but not the feeder cell-derived wild-
type allele. The measurements of Zfx expression (Figure 1A) were per-
formed using the calibration curve method. All other cDNA and geno-
mic DNA measurements were performed using the DDCT method on
MX3000P instrument (Stratagene).356 Cell 129, 345–357, April 20, 2007 ª2007 Elsevier Inc.Chromatin Immunoprecipitation
An ESC clone expressing FLAG-HA epitope-tagged Zfx protein (Zfx-
TAG) was generated as described in Supplemental Experimental Pro-
cedures. Zfx-TAG cells or parental Zfxnull cells were crosslinked with
formaldehyde and subjected to chromatin immunoprecipitation
(ChIP) using anti-FLAG M2 antibody (Sigma) or control IgG as de-
scribed (Boyer et al., 2005). After crosslink reversal, precipitated chro-
matin was analyzed by qPCR for genomic fragments of interest. For
experiments shown in Figure 7E, ChIP was performed using anti-Zfx
antibody or control IgG, followed by whole genome ligation-mediated
PCR amplification as described (Boyer et al., 2005). All results were
normalized using a control genomic DNA fragment from murine
Snai3 gene, which was not enriched in Zfx ChIP.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, twelve figures, and three tables and can
be found with this article online at http://www.cell.com/cgi/content/
full/129/2/345/DC1/.
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